Today, Hong Kong’s Health Authority continues to choose CSL Biotherapies as Hong Kong’s national plasma fractionator. Regulated by the Therapeutic Goods Administration, a regulator held in high regard worldwide, and Hong Kong’s Department of Health, Pharmaceuticals Registration and Import/Export Control Section, CSL Biotherapies and the Hong Kong Red Cross Blood Transfusion Service ensure that the blood and plasma donations made voluntarily by people living in Hong Kong continue to deliver the benefits that toll fractionation provides – a sustainable, reliable and high quality source of plasma-derived therapies, developed to treat serious medical conditions including immunodeficiency disorders, a range of haematological and neurological disorders, haemophilia and trauma.

Blood and plasma donated by Hong Kong’s donors is fractionated into five plasma-derived therapeutics at CSL Biotherapies' unique, purpose-built, chromatographic plasma fractionation facility, located at Broadmeadows in Victoria, Australia.

For more information about these products, please refer to the table below.

A-Z of Hong Kong products

B I N P

Product Name	Subcategory	Description
B
BIOSTATE^®	Coagulation Disorders	Used for patients with haemophilia A, in which there are reduced levels of factor VIII.
I
INTRAGAM^® P	Immune Therapy	Used to replace antibodies to help prevent infections and also used in the treatment of some autoimmune disorders.
N
Albumex® 5	Critical Care	Used when the blood volume is low, during heart-lung bypass surgery, and in plasma exchange.
Albumex® 20	Critical Care	Used when quantity of albumin in blood is low, for resuscitation in shock, in extensive burns, respiratory distress syndrome, blood purification and plasma exchange.
P
PROTHROMBINEX™-HT	Coagulation Disorders	Used for the prevention and treatment of bleeding in patients with reduced levels of factor IX, II or X.

CSL | Privacy | Terms of Use | Webmaster